Detalles de la búsqueda
1.
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 122(7): 1119, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949268
2.
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Breast Cancer Res Treat
; 181(2): 347-359, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274665
3.
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 120(10): 959-967, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30967649
4.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 19(1): 127-138, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158011
5.
Efficacy of a telephone outcall program to reduce caregiver burden among caregivers of cancer patients [PROTECT]: a randomised controlled trial.
BMC Cancer
; 18(1): 59, 2018 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29310613
6.
Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options.
Support Care Cancer
; 24(5): 2139-2146, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26556210
7.
Efficacy and cost-effectiveness of an outcall program to reduce carer burden and depression among carers of cancer patients [PROTECT]: rationale and design of a randomized controlled trial.
BMC Health Serv Res
; 14: 5, 2014 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24393305
8.
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Breast Cancer Res Treat
; 131(1): 295-306, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21892704
9.
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
Clin Cancer Res
; 27(2): 504-512, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33082214
10.
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.
J Clin Oncol
; 34(21): 2452-9, 2016 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27217455
11.
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.
J Clin Oncol
; 34(28): 3400-8, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27325862
12.
Is chemotherapy dose intensity adequate in breast cancer management in the Australian healthcare setting: a retrospective analysis.
Asia Pac J Clin Oncol
; 10(2): e54-62, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22989364
13.
Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives.
Asia Pac J Clin Oncol
; 10 Suppl S4: 15-25, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24797446
14.
Systemic treatment of HER2-positive metastatic breast cancer: a systematic review.
Asia Pac J Clin Oncol
; 10 Suppl S4: 1-14, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24797445
15.
Rational use of trastuzumab in metastatic and locally advanced breast cancer: implications of recent research.
Breast
; 20(2): 101-10, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21183347
16.
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
J Clin Oncol
; 29(9): 1117-24, 2011 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21321298
17.
Does multidisciplinary care enhance the management of advanced breast cancer?: evaluation of advanced breast cancer multidisciplinary team meetings.
J Oncol Pract
; 6(6): 294-300, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21358959
18.
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
J Clin Oncol
; 26(12): 1972-9, 2008 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18332471
19.
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
J Clin Oncol
; 25(5): 486-92, 2007 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17200148
Resultados
1 -
19
de 19
1
Próxima >
>>